BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nelson CS, Herold BC, Permar SR. A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection. NPJ Vaccines 2018;3:38. [PMID: 30275984 DOI: 10.1038/s41541-018-0074-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Martin M, Holmes S, Sim J, Hassan M, Mathew R, Bensen R, Barakat M. Foregone Inclusion: Neonatal CMV Hepatitis and Cholestasis. Dig Dis Sci 2019;64:3092-5. [PMID: 31187327 DOI: 10.1007/s10620-019-05691-7] [Reference Citation Analysis]
2 Galitska G, Coscia A, Forni D, Steinbrueck L, De Meo S, Biolatti M, De Andrea M, Cagliani R, Leone A, Bertino E, Schulz T, Santoni A, Landolfo S, Sironi M, Cerboni C, Dell'Oste V. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ. Front Immunol 2021;12:532484. [PMID: 33897679 DOI: 10.3389/fimmu.2021.532484] [Reference Citation Analysis]
3 El-Hamdi NS, Choi KY, McGregor A. Guinea pig cytomegalovirus trimer complex gH/gL/gO uses PDGFRA as universal receptor for cell fusion and entry. Virology 2020;548:236-49. [PMID: 32791352 DOI: 10.1016/j.virol.2020.05.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rios L, Campos EE, Menon R, Zago MP, Garg NJ. Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease. Biochim Biophys Acta Mol Basis Dis 2020;1866:165591. [PMID: 31678160 DOI: 10.1016/j.bbadis.2019.165591] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
5 Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR. Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease. J Infect Dis 2020;221:S45-59. [PMID: 32134477 DOI: 10.1093/infdis/jiz428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Aschner CB, Herold BC. Alphaherpesvirus Vaccines. Curr Issues Mol Biol 2021;41:469-508. [PMID: 32963118 DOI: 10.21775/cimb.041.469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cui X, Cao Z, Wang S, Adler SP, McVoy MA, Snapper CM. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities. Vaccines (Basel) 2020;8:E179. [PMID: 32294946 DOI: 10.3390/vaccines8020179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Awasthi S, Hook LM, Swaminathan G, Cairns TM, Brooks B, Smith JS, Ditto NT, Gindy ME, Bett AJ, Espeseth AS, Cohen GH, Friedman HM. Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants. Vaccine 2019;37:3770-8. [PMID: 31153687 DOI: 10.1016/j.vaccine.2019.05.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cui X, Cao Z, Wang S, Flora M, Adler SP, McVoy MA, Snapper CM. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity. Int J Mol Sci 2019;20:E3158. [PMID: 31261659 DOI: 10.3390/ijms20133158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Nelson CS, Vera Cruz D, Su M, Xie G, Vandergrift N, Pass RF, Forman M, Diener-West M, Koelle K, Arav-Boger R, Permar SR. Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. J Virol 2019;93:e01695-18. [PMID: 30518646 DOI: 10.1128/JVI.01695-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
11 Lee SJ, Park HJ, Ko HL, Lee JE, Lee HJ, Kim H, Nam JH. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Immun Inflamm Dis 2020;8:216-27. [PMID: 32167678 DOI: 10.1002/iid3.297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Burn Aschner C, Loh LN, Galen B, Delwel I, Jangra RK, Garforth SJ, Chandran K, Almo S, Jacobs WR Jr, Ware CF, Herold BC. HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses. Sci Immunol 2020;5:eaax2454. [PMID: 32817296 DOI: 10.1126/sciimmunol.aax2454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mancebo FJ, Parras-Moltó M, García-Ríos E, Pérez-Romero P. Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome. Int J Mol Sci 2022;23:2768. [PMID: 35269907 DOI: 10.3390/ijms23052768] [Reference Citation Analysis]
14 Scarpini S, Morigi F, Betti L, Dondi A, Biagi C, Lanari M. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines (Basel) 2021;9:551. [PMID: 34070277 DOI: 10.3390/vaccines9060551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cui X, Snapper CM. Development of novel vaccines against human cytomegalovirus. Hum Vaccin Immunother 2019;15:2673-83. [PMID: 31017831 DOI: 10.1080/21645515.2019.1593729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
16 Semmes EC, Hurst JH, Walsh KM, Permar SR. Cytomegalovirus as an immunomodulator across the lifespan. Curr Opin Virol 2020;44:112-20. [PMID: 32818717 DOI: 10.1016/j.coviro.2020.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
17 Eberhard S, Vietzen H, Görzer I, Jaksch P, Puchhammer-Stöckl E. Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant Recipients. Int J Mol Sci 2021;22:8206. [PMID: 34360986 DOI: 10.3390/ijms22158206] [Reference Citation Analysis]
18 Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR. Vaccines for Perinatal and Congenital Infections-How Close Are We? Front Pediatr 2020;8:569. [PMID: 33384972 DOI: 10.3389/fped.2020.00569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
19 Esposito S, Chiopris G, Messina G, D'Alvano T, Perrone S, Principi N. Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Vaccines (Basel) 2021;9:523. [PMID: 34069321 DOI: 10.3390/vaccines9050523] [Reference Citation Analysis]
20 Foglierini M, Marcandalli J, Perez L. HCMV Envelope Glycoprotein Diversity Demystified. Front Microbiol 2019;10:1005. [PMID: 31156572 DOI: 10.3389/fmicb.2019.01005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
21 Contreras H, Wussow F, Fernández-Alarcón C, Bierle C, Nguyen J, Diamond DJ, Schleiss MR. MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission. Vaccines (Basel) 2019;7:E182. [PMID: 31739399 DOI: 10.3390/vaccines7040182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Barry PA, Deere JD, Yue Y, Chang WWL, Schmidt KA, Wussow F, Chiuppesi F, Diamond DJ, Sparger EE, Walter MR, Hartigan-O'Connor DJ. Cytomegalovirus-vectored vaccines for HIV and other pathogens. AIDS 2020;34:335-49. [PMID: 31634191 DOI: 10.1097/QAD.0000000000002396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zeng C, Zhang C, Walker PG, Dong Y. Formulation and Delivery Technologies for mRNA Vaccines. Curr Top Microbiol Immunol 2020. [PMID: 32483657 DOI: 10.1007/82_2020_217] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
24 Sweet C. Lessons from studies with murine cytomegalovirus that could lead to a safe live attenuated vaccine for human cytomegalovirus. Access Microbiol 2020;2:acmi000147. [PMID: 33195979 DOI: 10.1099/acmi.0.000147] [Reference Citation Analysis]
25 Perotti M, Perez L. Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV. Viruses 2019;12:E35. [PMID: 31905677 DOI: 10.3390/v12010035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
26 Vietzen H, Görzer I, Honsig C, Jaksch P, Puchhammer-Stöckl E. Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation. J Infect Dis 2020;222:417-27. [PMID: 32157310 DOI: 10.1093/infdis/jiaa097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Nelson CS, Jenks JA, Pardi N, Goodwin M, Roark H, Edwards W, McLellan JS, Pollara J, Weissman D, Permar SR. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization. J Virol 2020;94:e00186-20. [PMID: 32051265 DOI: 10.1128/JVI.00186-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]